407 related articles for article (PubMed ID: 24430319)
1. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
[TBL] [Abstract][Full Text] [Related]
3. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
[TBL] [Abstract][Full Text] [Related]
4. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
5. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
[TBL] [Abstract][Full Text] [Related]
6. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
[TBL] [Abstract][Full Text] [Related]
7. Extensive scheduled CT and CEA follow-up are equivalent in detecting recurrent colorectal cancer that is surgically treatable with curative intent, and superior to minimal follow up.
Taylor SA
Evid Based Med; 2014 Aug; 19(4):149. PubMed ID: 24677786
[No Abstract] [Full Text] [Related]
8. What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.
Shinkins B; Nicholson BD; James T; Pathiraja I; Pugh S; Perera R; Primrose J; Mant D
Health Technol Assess; 2017 Apr; 21(22):1-60. PubMed ID: 28617240
[TBL] [Abstract][Full Text] [Related]
9. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
Shinkins B; Primrose JN; Pugh SA; Nicholson BD; Perera R; James T; Mant D
Br J Surg; 2018 May; 105(6):658-662. PubMed ID: 29579327
[TBL] [Abstract][Full Text] [Related]
10. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
[TBL] [Abstract][Full Text] [Related]
11. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
[TBL] [Abstract][Full Text] [Related]
12. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I;
Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037
[TBL] [Abstract][Full Text] [Related]
13. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
[TBL] [Abstract][Full Text] [Related]
14. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
[TBL] [Abstract][Full Text] [Related]
15. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
[TBL] [Abstract][Full Text] [Related]
16. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
[TBL] [Abstract][Full Text] [Related]
17. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
[TBL] [Abstract][Full Text] [Related]
18. Results of long-term follow-up after curative resection of Dukes A colorectal cancer.
Wichmann MW; Müller C; Hornung HM; Lau-Werner U; Schildberg FW;
World J Surg; 2002 Jun; 26(6):732-6. PubMed ID: 12053228
[TBL] [Abstract][Full Text] [Related]
19. Follow-up strategies for patients treated for non-metastatic colorectal cancer.
Jeffery M; Hickey BE; Hider PN
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002200. PubMed ID: 31483854
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent.
Gunawardene A; Larsen P; Shekouh A; Dennett E
ANZ J Surg; 2018 Dec; 88(12):1311-1315. PubMed ID: 30066426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
